00000000|MMI|19.26|Diabetic Foot|C0206172|[dsyn]|["Diabetic Foot"-tx-1-"diabetic foot"-noun-0]|TX|65/13|C14.907.320.191;C17.800.893.592.450.200;C19.246.099.500.191;C19.246.099.937.250
00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|116/13|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.49|10 - 19|C3843800|[fndg]|["10 - 19"-tx-1-"10/19"-fraction-0]|TX|105/5|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|132.06|Override|C1547671|[acty]|["Override"-tx-15-"Override"-verb-0,"Override"-tx-15-"overridden"-noun-0,"Override"-tx-15-"override"-verb-0,"Override"-tx-14-"override"-verb-0,"Override"-tx-11-"Override"-verb-0,"Override"-tx-11-"overridden"-noun-0,"Override"-tx-10-"override"-verb-0,"Override"-tx-8-"Override"-verb-0,"Override"-tx-8-"override"-verb-0,"Override"-tx-6-"Override"-verb-0,"Override"-tx-6-"override"-verb-0,"Override"-tx-4-"Override"-verb-0]|TX|2021/8;2009/10;2119/8;1646/8;1510/8;1498/10;1358/8;1175/8;[1118/8],[1153/8];[910/8],[927/8];642/8;[422/8],[439/8]|
00000000|MMI|106.66|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-42-"INR"-noun-0,"INR"-tx-16-"INR's"-noun-0,"INR"-tx-15-"INR"-noun-0,"INR"-tx-15-"INR's"-noun-0,"INR"-tx-8-"INR"-noun-0,"INR"-tx-6-"INR"-noun-0]|TX|5175/3;2319/5;2250/3;2287/5;1140/3;830/3|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|87.31|Portugal|C0032729|[geoa]|["PO"-tx-15-"PO"-noun-0,"PO"-tx-14-"PO"-noun-0,"PO"-tx-10-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|1963/2;1734/2;[1265/2],[1403/2];1019/2;[540/2],[765/2];[361/2],[397/2]|Z01.542.727
00000000|MMI|86.74|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-43-"DISCHARGE"-noun-0,"Discharge"-tx-42-"DISCHARGE"-noun-0,"Discharge"-tx-16-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5349/9;5110/9;2409/9;39/9;113/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|79.95|Togo|C0040363|[geoa]|["TO"-tx-42-"to"-adv-0,"TO"-tx-35-"to"-adv-0,"TO"-tx-21-"to"-adv-0,"TO"-tx-15-"to"-adv-0]|TX|5054/2;4573/2;3501/2;[2254/2],[2293/2]|Z01.058.290.190.800
00000000|MMI|79.95|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-42-"to"-adv-0,"TO"-tx-35-"to"-adv-0,"TO"-tx-21-"to"-adv-0,"TO"-tx-15-"to"-adv-0]|TX|5054/2;4573/2;3501/2;[2254/2],[2293/2]|D08.811.520.224.800
00000000|MMI|79.46|Warfarin|C0043031|[hops,orch,phsu]|["WARFARIN"-tx-15-"WARFARIN"-noun-0,"WARFARIN"-tx-14-"WARFARIN"-noun-0,"WARFARIN"-tx-10-"WARFARIN"-noun-0,"WARFARIN"-tx-8-"WARFARIN"-noun-0]|TX|2085/8;1608/8;1320/8;1074/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|72.82|Papillon-Lefevre Disease|C0030360|[dsyn]|["PLS"-tx-42-"Pls"-noun-0,"PLS"-tx-42-"pls"-noun-0]|TX|[4960/3],[5031/3];[4894/3],[5003/3],[5075/3]|C16.320.850.475.600;C17.800.428.435.600;C17.800.827.475.600
00000000|MMI|68.93|Diabetic Foot|C0206172|[dsyn]|["diabetic foot ulcers"-tx-26-"ulcer diabetic foot"-noun-0,"Diabetic Foot"-tx-16-"diabetic foot"-noun-0,"Diabetic Foot"-tx-16-"diabetic foot"-noun-1,"diabetic foot ulcer"-tx-16-"Diabetic foot ulcer"-noun-0]|TX|4188/5,4196/13;[2385/13],[2478/13];[2385/13],[2478/13];3014/19|C14.907.320.191;C17.800.893.592.450.200;C19.246.099.500.191;C19.246.099.937.250
00000000|MMI|67.11|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-14-"SIMVASTATIN"-noun-0,"SIMVASTATIN"-tx-10-"SIMVASTATIN"-noun-0]|TX|1623/11;[1253/11],[1335/11]|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|59.46|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-40-"coumadin"-noun-0,"Coumadin"-tx-16-"coumadin"-noun-0,"Coumadin"-tx-6-"COUMADIN"-noun-0]|TX|4793/8;3107/8;731/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|58.92|Coding|C0009219|[ocac]|["code"-tx-42-"CODE"-noun-0,"code"-tx-4-"CODE"-noun-0,"code"-tx-4-"code"-noun-0]|TX|4868/4;280/4;298/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|52.93|Obesity|C0028754|[dsyn]|["OBESITY"-tx-16-"obesity"-noun-0]|TX|[2654/7],[2664/7]|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|50.93|linezolid|C0663241|[orch,phsu]|["Linezolide"-tx-42-"linezolid"-noun-0,"Linezolide"-tx-31-"linezolid"-noun-0,"Linezolide"-tx-19-"Linezolid"-noun-0]|TX|5155/9;4432/9;3382/9|D02.065.064.463;D02.241.081.018.110.525;D03.383.129.462.600.550
00000000|MMI|49.92|Aspirin|C0004057|[orch,phsu]|["ASPIRIN"-tx-15-"ASPIRIN"-noun-0,"Acetylsalicylic Acid"-tx-15-"ACETYLSALICYLIC ACID"-noun-0]|TX|2100/7;1969/20|D02.455.426.559.389.657.410.595.176
00000000|MMI|46.48|Pneumocystis jiroveci pneumonia|C1535939|[dsyn]|["PCP"-tx-42-"PCP"-noun-0,"PCP"-tx-16-"PCP"-noun-0,"PCP"-tx-15-"pcp"-noun-0]|TX|[5027/3],[5246/3];2345/3;2236/3|C01.703.534.700;C01.703.770.700;C08.381.472.700;C08.381.677.675;C08.730.435.700;C08.730.610.675
00000000|MMI|45.94|Rabbi|C0684010|[prog]|["R."-tx-23-"R"-noun-0,"R."-tx-18-"R"-noun-0,"R."-tx-16-"R"-noun-0,"R."-tx-16-"r"-noun-0]|TX|3851/1;3310/1;2905/1;2859/1|M01.526.799.500
00000000|MMI|45.94|amsacrine/azacitidine/etoposide|C0083355|[topp]|["AVA"-tx-11-"AVA"-noun-0,"AVA"-tx-8-"AVA"-noun-0,"AVA"-tx-6-"AVA"-noun-0,"AVA"-tx-4-"AVA"-noun-0]|TX|1552/3;1217/3;969/3;482/3|x.x.x.x
00000000|MMI|42.39|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-14-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-10-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-6-"Food/Drug Interaction"-noun-0]|TX|1765/21;1410/21;841/21|G07.690.773.968.511
00000000|MMI|41.95|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-16-"DIAGNOSIS"-noun-0]|TX|[2374/9],[2498/9]|x.x.x.x.x.x.x
00000000|MMI|39.51|Surgical aspects|C0038895|[ftcn]|["operations"-tx-16-"OPERATIONS"-noun-0,"surgery"-tx-15-"surgery"-noun-0]|TX|2817/10;2226/7|x.x.x.x.x.x.x
00000000|MMI|38.66|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-35-"Pt"-noun-0,"PT"-tx-35-"pt"-noun-0,"PT"-tx-27-"Pt"-noun-0,"PT"-tx-22-"Pt"-noun-0,"PT"-tx-21-"pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-19-"pt"-noun-0,"PT"-tx-18-"Pt"-noun-0,"PT"-tx-14-"pt"-noun-0,"PT"-tx-10-"pt"-noun-0]|TX|4570/2;4591/2;4230/2;3587/2;3460/2;3422/2;3399/2;3266/2;1656/2;1368/2|
00000000|MMI|38.66|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-35-"Pt"-noun-0,"PT"-tx-35-"pt"-noun-0,"PT"-tx-27-"Pt"-noun-0,"PT"-tx-22-"Pt"-noun-0,"PT"-tx-21-"pt"-noun-0,"PT"-tx-20-"pt"-noun-0,"PT"-tx-19-"pt"-noun-0,"PT"-tx-18-"Pt"-noun-0,"PT"-tx-14-"pt"-noun-0,"PT"-tx-10-"pt"-noun-0]|TX|4570/2;4591/2;4230/2;3587/2;3460/2;3422/2;3399/2;3266/2;1656/2;1368/2|
00000000|MMI|34.85|Ulcer|C0041582|[dsyn]|["ULCER"-tx-23-"ulcer"-noun-0,"ULCER"-tx-21-"ulcer"-noun-0,"Ulceration"-tx-16-"ulceration"-noun-0,"ulcerations"-tx-16-"ulcerations"-noun-0]|TX|3908/5;3485/5;2982/10;3152/11|C23.550.891
00000000|MMI|33.93|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-42-"M.D"-noun-0,"M.D."-tx-14-"M.D"-noun-0,"M.D."-tx-12-"M.D"-noun-0,"M.D."-tx-9-"M.D"-noun-0,"M.D."-tx-7-"M.D"-noun-0,"M.D."-tx-5-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0]|TX|5303/3;1883/3;1561/3;1226/3;978/3;491/3;267/3|
00000000|MMI|33.59|District of Columbia|C0012764|[geoa]|["D.C."-tx-31-"D/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|4401/3;191/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|33.43|Didanosine|C0012133|[nnon,phsu]|["DDI"-tx-40-"DDI"-noun-0,"DDI"-tx-16-"DDI"-noun-0]|TX|4772/3;3094/3|D03.438.759.590.616.130;D13.570.230.500.090;D13.570.583.616.130;D13.570.800.573.130
00000000|MMI|30.97|Cellulitis|C0007642|[patf]|["CELLULITIS"-tx-18-"cellulitis"-noun-0,"CELLULITIS"-tx-16-"cellulitis"-noun-0]|TX|3295/10;2697/10|C01.539.800.130;C01.539.830.200;C17.300.185;C23.550.470.756.200
00000000|MMI|30.97|Mitral Valve Prolapse Syndrome|C0026267|[dsyn]|["MITRAL VALVE PROLAPSE"-tx-16-"mitral valve prolapse"-noun-0,"Mitral prolapse"-tx-16-"mitral prolapse"-noun-0]|TX|2728/21;2710/15|C14.280.484.400.500
00000000|MMI|30.84|Oral|C0442027|[spco]|["PO"-tx-15-"PO"-noun-0,"PO"-tx-14-"PO"-noun-0,"PO"-tx-10-"PO"-noun-0,"PO"-tx-8-"PO"-noun-0,"PO"-tx-6-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0]|TX|1963/2;1734/2;[1265/2],[1403/2];1019/2;[540/2],[765/2];[361/2],[397/2]|
00000000|MMI|28.03|Dominican Republic|C0013014|[geoa]|["DR"-tx-42-"Dr"-noun-0,"DR"-tx-24-"Dr"-noun-0]|TX|4936/2;4146/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|26.35|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-10-"grapefruit"-noun-0]|TX|1450/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|25.48|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-41-"baseline"-noun-0,"baseline"-tx-37-"Baseline"-noun-0]|TX|4845/8;4680/8|x.x.x.x
00000000|MMI|25.48|Consultation|C0009818|[hlca]|["consulted"-tx-30-"consulted"-verb-0,"Consults"-tx-24-"CONSULTS"-verb-0]|TX|4375/9;4103/8|N04.452.758.849
00000000|MMI|25.48|Urinary tract infection|C0042029|[dsyn]|["URINARY TRACT INFECTION"-tx-16-"urinary tract infection"-noun-0,"UTI"-tx-16-"uti"-noun-0]|TX|2758/23;2752/3|C01.539.895;C12.777.892;C13.351.968.892
00000000|MMI|24.20|Order (action)|C1705178|[acty]|["Order"-tx-43-"ORDERS"-verb-0,"Order"-tx-14-"order"-noun-0,"Order"-tx-10-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5359/6;1804/5;1243/5;995/5;508/5;195/5;49/6|
00000000|MMI|24.20|Order (arrangement)|C1705176|[qlco]|["Order"-tx-43-"ORDERS"-verb-0,"Order"-tx-14-"order"-noun-0,"Order"-tx-10-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5359/6;1804/5;1243/5;995/5;508/5;195/5;49/6|
00000000|MMI|24.20|Order (document)|C1705175|[inpr]|["Order"-tx-43-"ORDERS"-verb-0,"Order"-tx-14-"order"-noun-0,"Order"-tx-10-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5359/6;1804/5;1243/5;995/5;508/5;195/5;49/6|
00000000|MMI|24.20|Order (taxonomic)|C1705177|[clas]|["Order"-tx-43-"ORDERS"-verb-0,"Order"-tx-14-"order"-noun-0,"Order"-tx-10-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5359/6;1804/5;1243/5;995/5;508/5;195/5;49/6|
00000000|MMI|24.20|Permutation|C1882348|[qlco]|["Order"-tx-43-"ORDERS"-verb-0,"Order"-tx-14-"order"-noun-0,"Order"-tx-10-"order"-noun-0,"Order"-tx-8-"order"-noun-0,"Order"-tx-6-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5359/6;1804/5;1243/5;995/5;508/5;195/5;49/6|
00000000|MMI|24.20|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-43-"ORDERS"-verb-0,"ORDER"-tx-14-"order"-noun-0,"ORDER"-tx-10-"order"-noun-0,"ORDER"-tx-8-"order"-noun-0,"ORDER"-tx-6-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5359/6;1804/5;1243/5;995/5;508/5;195/5;49/6|
00000000|MMI|23.55|Blood Vessel|C0005847|[bpoc]|["Vascular"-tx-42-"vascular"-adj-0,"Vascular"-tx-34-"vascular"-adj-0,"Vascular"-tx-24-"vascular"-adj-0,"Vascular"-tx-21-"vascular"-adj-0]|TX|5233/8;4524/8;3960/8;3566/8|A07.231
00000000|MMI|23.28|To|C1883351|[qlco]|["To"-tx-42-"to"-adv-0,"To"-tx-35-"to"-adv-0,"To"-tx-21-"to"-adv-0,"To"-tx-15-"to"-adv-0]|TX|5054/2;4573/2;3501/2;[2254/2],[2293/2]|
00000000|MMI|23.05|10%|C3842590|[fndg]|["10%"-tx-42-"10"-fraction-0,"10%"-tx-35-"10"-fraction-0,"10%"-tx-18-"10"-fraction-0,"10%"-tx-15-"10"-fraction-0,"10%"-tx-15-"10"-integer-0,"10%"-tx-4-"10"-fraction-0]|TX|[4951/2],[5188/2];4614/2;3285/2;[1930/2],[2269/2];[1930/2],[2269/2];457/2|
00000000|MMI|23.05|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-16-"diabetes mellitus"-noun-0,"Diabetes"-tx-16-"diabetes"-noun-0]|TX|2586/17;2575/8|C18.452.394.750;C19.246
00000000|MMI|22.87|Diet|C0012155|[food]|["Diet"-tx-39-"diet"-noun-0,"Diet"-tx-15-"DIET"-noun-0]|TX|4738/4;2132/4|G07.203.650.240
00000000|MMI|22.62|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-31-"D/c"-noun-0,"D & C"-tx-1-"D/C"-noun-0]|TX|4401/3;191/3|E04.157.310;E04.950.300.299
00000000|MMI|22.61|Panama|C0030266|[geoa]|["PM"-tx-43-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5332/2;152/2|Z01.107.169.772
00000000|MMI|22.54|Physicians|C0031831|[prog]|["DR"-tx-42-"Dr"-noun-0,"DR"-tx-24-"Dr"-noun-0]|TX|4936/2;4146/2|M01.526.485.810;N02.360.810
00000000|MMI|22.15|Vitamin K|C0042878|[orch,vita]|["VITAMIN K"-tx-6-"Vitamin-K"-noun-0]|TX|883/9|D02.455.426.559.847.638.721.374;D02.455.849.291.523.500;D04.615.638.721.374;x.x.x.x
00000000|MMI|20.88|Warfarin Sodium|C0376218|[hops,orch,phsu]|["WARFARIN SODIUM"-tx-6-"WARFARIN SODIUM"-noun-0]|TX|742/15|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|20.11|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-42-"INR"-noun-0,"INR"-tx-16-"INR's"-noun-0,"INR"-tx-15-"INR"-noun-0,"INR"-tx-15-"INR's"-noun-0,"INR"-tx-8-"INR"-noun-0,"INR"-tx-6-"INR"-noun-0]|TX|5175/3;2319/5;2250/3;2287/5;1140/3;830/3|
00000000|MMI|19.99|Edema|C0013604|[fndg]|["OEDEMA"-tx-23-"edema"-noun-0,"OEDEMA"-tx-16-"edema"-noun-0]|TX|3933/5;2627/5|C23.888.277
00000000|MMI|19.99|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-16-"htn"-noun-0,"HYPERTENSION"-tx-16-"hypertension"-noun-0]|TX|2606/3;2612/12|C14.907.489
00000000|MMI|19.48|Antibiotics, Antitubercular|C0003237|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|D27.505.954.122.085.255.135
00000000|MMI|19.40|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-16-"Treatment"-noun-0]|TX|2560/9|x.x.x.x.x.x.x
00000000|MMI|18.36|Master of Public Health|C1513008|[inpr]|["M.P.H."-tx-13-"M.P.H"-noun-0,"M.P.H."-tx-10-"M.P.H"-noun-0,"M.P.H."-tx-8-"M.P.H"-noun-0,"M.P.H."-tx-6-"M.P.H"-noun-0]|TX|1568/5;1233/5;985/5;498/5|
00000000|MMI|18.15|Cipro|C0701042|[orch,phsu]|["Cipro"-tx-27-"cipro"-noun-0]|TX|4253/5|D03.438.810.835.322.186
00000000|MMI|18.15|Esomeprazole|C0937846|[orch,phsu]|["ESOMEPRAZOLE"-tx-15-"ESOMEPRAZOLE"-noun-0]|TX|1942/12|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|17.76|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-14-"Instruction"-noun-0,"Instruction"-tx-10-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0]|TX|1787/11;1432/11;863/11|I02.903
00000000|MMI|17.64|Methods aspects|C0025664|[inpr]|["procedures"-tx-24-"PROCEDURES"-noun-0,"procedures"-tx-16-"PROCEDURES"-noun-0]|TX|4040/10;2832/10|x.x.x
00000000|MMI|17.38|Diet therapy|C0012159|[hlca]|["Diet"-tx-39-"diet"-noun-0,"Diet"-tx-15-"DIET"-noun-0]|TX|4738/4;2132/4|E02.642.249
00000000|MMI|17.34|Drawings (art)|C0013113|[inpr]|["Draw"-tx-15-"drawn"-verb-0]|TX|[2260/5],[2299/5]|V01.185.625;V02.700.300
00000000|MMI|17.23|Female|C0015780|[orga]|["FEMALE"-tx-16-"female"-noun-0]|TX|[2963/6],[3049/6]|x.x.x
00000000|MMI|17.23|Females|C0086287|[popg]|["female"-tx-16-"female"-noun-0]|TX|[2963/6],[3049/6]|x.x.x
00000000|MMI|17.22|Bone Tissue|C0391978|[tisu]|["BONE"-tx-32-"bone"-noun-0,"BONE"-tx-21-"bone"-noun-0]|TX|4487/4;3514/4|A02.835.232;A10.165.265
00000000|MMI|17.20|Disease|C0012634|[dsyn]|["condition"-tx-42-"CONDITION"-noun-0,"condition"-tx-16-"Conditions"-noun-0]|TX|5120/9;2508/10|C23.550.288
00000000|MMI|17.18|Appointments|C0003629|[idcn]|["Appointments"-tx-42-"appointments"-noun-0,"Appointment"-tx-15-"APPOINTMENT"-noun-0]|TX|5207/12;2198/11|N04.452.095
00000000|MMI|17.14|Identifier|C0600091|[inpr]|["ID"-tx-31-"ID"-noun-0,"ID"-tx-30-"ID"-noun-0,"ID"-tx-24-"ID"-noun-0,"ID"-tx-20-"ID"-noun-0,"ID"-tx-16-"ID"-noun-0]|TX|4386/2;4367/2;4118/2;3447/2;2953/2|
00000000|MMI|17.14|Immune diffusion|C1441613|[lbpr]|["ID"-tx-31-"ID"-noun-0,"ID"-tx-30-"ID"-noun-0,"ID"-tx-24-"ID"-noun-0,"ID"-tx-20-"ID"-noun-0,"ID"-tx-16-"ID"-noun-0]|TX|4386/2;4367/2;4118/2;3447/2;2953/2|
00000000|MMI|16.98|Sao Tome and Principe|C0036183|[geoa]|["TP"-tx-14-"TP"-noun-0,"TP"-tx-6-"TP"-noun-0]|TX|1710/2;676/2|Z01.639.040
00000000|MMI|16.85|Nexium|C0939400|[orch,phsu]|["Nexium"-tx-15-"NEXIUM"-noun-0]|TX|1933/6|D02.886.640.074.500.500;D03.383.725.024.500.500;D03.438.103.034.500.500
00000000|MMI|16.85|Nuchal Translucency Screen|C1449832|[diap]|["NT"-tx-23-"NT"-noun-0]|TX|3793/2|E01.370.350.850.865.500;E01.370.378.630.865.500
00000000|MMI|16.69|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-23-"NAD"-noun-0]|TX|3697/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|16.68|Ciprofloxacin Hydrochloride|C0282104|[antb,orch]|["ciprofloxacin hcl"-tx-8-"CIPROFLOXACIN HCL"-noun-0]|TX|1089/17|D03.438.810.835.322.186
00000000|MMI|16.63|Chronic Kidney Diseases|C1561643|[dsyn]|["CKD"-tx-41-"CKD"-noun-0]|TX|4811/3|C12.777.419.780.750;C13.351.968.419.780.750
00000000|MMI|16.63|Ciprofloxacin|C0008809|[orch,phsu]|["CIPROFLOXACIN"-tx-8-"CIPROFLOXACIN"-noun-0]|TX|1005/13|D03.438.810.835.322.186
00000000|MMI|16.32|Interaction|C1704675|[ftcn]|["Interaction"-tx-15-"INTERACTION"-noun-0,"Interaction"-tx-14-"INTERACTION"-noun-0,"Interaction"-tx-10-"INTERACTION"-noun-0,"Interaction"-tx-8-"INTERACTION"-noun-0,"Interaction"-tx-6-"INTERACTION"-noun-0]|TX|2072/11;1595/11;1307/11;1061/11;582/11|
00000000|MMI|16.08|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-15-"Reason"-noun-0,"Reason"-tx-14-"Reason"-noun-0,"Reason"-tx-10-"Reason"-noun-0,"Reason"-tx-8-"Reason"-noun-0,"Reason"-tx-6-"Reason"-noun-0]|TX|2108/6;1635/6;1347/6;1107/6;631/6|
00000000|MMI|16.03|Daily|C0332173|[tmco]|["Daily"-tx-42-"daily"-adv-0,"QD"-tx-15-"QD"-noun-0,"QD"-tx-6-"QD"-noun-0,"QD"-tx-4-"QD"-noun-0]|TX|5044/5;1966/2;679/2;[364/2],[400/2]|
00000000|MMI|16.00|Ortho-|C0812371|[idcn]|["Ortho"-tx-42-"ortho"-adj-0,"Ortho"-tx-32-"Ortho"-adj-0,"Ortho"-tx-30-"Ortho"-adj-0,"Ortho"-tx-24-"Ortho"-adj-0,"Ortho"-tx-20-"ortho"-adj-0]|TX|5225/5;4443/5;4357/5;4126/5;3437/5|
00000000|MMI|15.98|Additional|C1524062|[ftcn]|["Added"-tx-15-"added"-verb-0,"Added"-tx-11-"added"-verb-0,"Added"-tx-8-"added"-verb-0,"Added"-tx-6-"added"-verb-0,"Added"-tx-4-"added"-verb-0]|TX|2030/5;1519/5;1184/5;936/5;448/5|
00000000|MMI|15.81|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-42-"Follow up"-adj-0,"FOLLOW-UP"-tx-42-"follow up"-adj-0,"FOLLOW-UP"-tx-15-"FOLLOW UP"-adj-0]|TX|5197/9;[4898/9],[4964/9],[5007/9];2188/9|
00000000|MMI|15.81|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-42-"Follow up"-adj-0,"Follow-Up"-tx-42-"follow up"-adj-0,"Follow-Up"-tx-15-"FOLLOW UP"-adj-0]|TX|5197/9;[4898/9],[4964/9],[5007/9];2188/9|
00000000|MMI|15.81|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-42-"Follow up"-adj-0,"Follow-up"-tx-42-"follow up"-adj-0,"Follow-up"-tx-15-"FOLLOW UP"-adj-1]|TX|5197/9;[4898/9],[4964/9],[5007/9];2188/9|
00000000|MMI|15.81|follow-up|C1522577|[hlca]|["Follow Up"-tx-42-"Follow up"-adj-0,"Follow Up"-tx-42-"follow up"-adj-0,"Follow Up"-tx-15-"FOLLOW UP"-adj-0]|TX|5197/9;[4898/9],[4964/9],[5007/9];2188/9|
00000000|MMI|15.66|Right|C0205090|[spco]|["R-"-tx-23-"R"-noun-0,"R-"-tx-18-"R"-noun-0,"RIGHT"-tx-17-"right"-noun-0,"R-"-tx-16-"R"-noun-0,"R-"-tx-16-"r"-noun-0]|TX|3851/1;3310/1;3259/5;2905/1;2859/1|
00000000|MMI|15.61|Serious|C0205404|[qlco]|["Serious"-tx-15-"SERIOUS"-adj-0,"Serious"-tx-14-"SERIOUS"-adj-0,"Serious"-tx-10-"SERIOUS"-adj-0,"Serious"-tx-8-"SERIOUS"-adj-0,"Serious"-tx-6-"SERIOUS"-adj-0]|TX|2064/7;1587/7;1299/7;1053/7;574/7|
00000000|MMI|15.42|Glyburide|C0017628|[orch,phsu]|["GLYBURIDE"-tx-39-"glyburide"-noun-0]|TX|4722/9|D02.886.590.795.575;D02.948.828.575
00000000|MMI|14.51|Infection|C3714514|[patf]|["Infections"-tx-16-"Infections"-noun-0,"Infections"-tx-16-"infections"-noun-0]|TX|2521/10;3168/10|C01.539
00000000|MMI|14.32|Entire left foot|C1279999|[bpoc]|["Left foot"-tx-24-"Left foot"-noun-0,"Left foot"-tx-23-"Left foot"-noun-0,"Left foot"-tx-21-"Left foot"-noun-0,"Left foot"-tx-17-"left foot"-noun-0]|TX|3981/9;3829/9;3523/9;3192/9|
00000000|MMI|14.32|Structure of left foot|C0230461|[bpoc]|["Left Foot"-tx-24-"Left foot"-noun-0,"Left Foot"-tx-23-"Left foot"-noun-0,"Left Foot"-tx-21-"Left foot"-noun-0,"Left Foot"-tx-17-"left foot"-noun-0]|TX|3981/9;3829/9;3523/9;3192/9|
00000000|MMI|14.18|Foot Ulcer|C0085119|[acab,dsyn]|["Foot Ulcer"-tx-18-"foot ulcer"-noun-0]|TX|3312/10|C17.800.321.250;C17.800.893.592.450
00000000|MMI|14.12|Lesotho|C0023376|[geoa]|["LT"-tx-4-"lt"-noun-0]|TX|416/2|Z01.058.290.175.400
00000000|MMI|14.12|Sick Sinus Syndrome|C0037052|[dsyn]|["SSS"-tx-40-"SSS"-noun-0]|TX|4762/3|C14.280.067.093.249;C14.280.067.558.536;C23.550.073.093.249;C23.550.073.425.440
00000000|MMI|14.06|Pain|C0030193|[sosy]|["PAIN"-tx-16-"pain"-noun-0]|TX|3001/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|14.02|Ivory Coast|C0022326|[geoa]|["IV"-tx-19-"IV"-noun-0]|TX|3345/2|Z01.058.290.190.272
00000000|MMI|14.01|Antibiotics|C0003232|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|D27.505.954.122.085
00000000|MMI|13.96|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-6-"LISINOPRIL"-noun-0]|TX|595/10|D12.644.456.345.600
00000000|MMI|13.94|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-6-"POTASSIUM CHLORIDE"-noun-0]|TX|612/18|D01.210.450.150.750;D01.745.625
00000000|MMI|13.94|Fluorides|C0016327|[inch,phsu]|["F-"-tx-15-"f"-noun-0]|TX|2283/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|13.92|Miconazole Nitrate|C0086620|[orch,phsu]|["MICONAZOLE NITRATE"-tx-14-"MICONAZOLE NITRATE"-noun-0]|TX|1673/18|D03.383.129.308.550
00000000|MMI|13.90|Lebanon|C0023190|[geoa]|["LE"-tx-16-"LE"-noun-0]|TX|3149/2|Z01.252.245.500.450
00000000|MMI|13.63|Hold (action)|C1948035|[acty]|["Hold"-tx-6-"HOLD"-verb-0,"Hold"-tx-4-"HOLD"-verb-0]|TX|821/4;[367/4],[403/4]|
00000000|MMI|13.63|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-6-"HOLD"-verb-0,"Hold"-tx-4-"HOLD"-verb-0]|TX|821/4;[367/4],[403/4]|
00000000|MMI|13.63|Take|C1515187|[hlca]|["Take"-tx-42-"take"-verb-0,"Take"-tx-14-"takes"-verb-0,"Take"-tx-10-"takes"-verb-0]|TX|5079/4;1659/5;1371/5|
00000000|MMI|13.63|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-6-"HOLD"-verb-0,"hold"-tx-4-"HOLD"-verb-0]|TX|821/4;[367/4],[403/4]|
00000000|MMI|13.01|Hospital admission|C0184666|[hlca]|["admitted"-tx-24-"admitted"-verb-0,"admitted"-tx-18-"admitted"-verb-0,"Admission"-tx-16-"Admission"-noun-0,"Admit"-tx-16-"ADMIT"-verb-0]|TX|4009/8;3273/8;2466/9;2368/5|
00000000|MMI|12.75|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-14-"Instruction"-noun-0,"Instruction"-tx-10-"Instruction"-noun-0,"Instruction"-tx-6-"Instruction"-noun-0,"instructions"-tx-6-"Instructions"-noun-0]|TX|1787/11;1432/11;863/11;682/12|
00000000|MMI|12.75|Instructions|C1442085|[idcn]|["instruction"-tx-14-"Instruction"-noun-0,"instruction"-tx-10-"Instruction"-noun-0,"Instructions"-tx-6-"Instructions"-noun-0,"instruction"-tx-6-"Instruction"-noun-0]|TX|1787/11;1432/11;682/12;863/11|
00000000|MMI|12.69|Dermatitis, Atopic|C0011615|[dsyn]|["ATOPIC DERMATITIS"-tx-16-"atopic dermatitis"-noun-0]|TX|2784/17|C16.320.850.210;C17.800.174.193;C17.800.815.193;C17.800.827.210;C20.543.480.343
00000000|MMI|12.69|Desiccation|C0011682|[npop]|["Dry"-tx-42-"dry"-verb-0]|TX|5057/3|E05.196.335;G02.149.767.530;G02.842.750.530
00000000|MMI|12.69|Eczema|C0013595|[dsyn]|["Atopic Dermatitis"-tx-16-"atopic dermatitis"-noun-0]|TX|2784/17|C17.800.174.620;C17.800.815.620
00000000|MMI|12.69|urinastatin|C0077906|[aapp,phsu]|["UTI"-tx-16-"uti"-noun-0]|TX|2752/3|x.x.x.x
00000000|MMI|12.48|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-43-"DISCHARGE"-noun-0,"Discharge"-tx-42-"DISCHARGE"-noun-0,"Discharge"-tx-16-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5349/9;5110/9;2409/9;39/9|
00000000|MMI|12.48|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-43-"DISCHARGE"-noun-0,"Discharge"-tx-42-"DISCHARGE"-noun-0,"Discharge"-tx-16-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5349/9;5110/9;2409/9;39/9|
00000000|MMI|12.41|R prime|C2603358|[clna]|["R'"-tx-23-"R"-noun-0,"R'"-tx-18-"R"-noun-0,"R'"-tx-16-"R"-noun-0,"R'"-tx-16-"r"-noun-0]|TX|3851/1;3310/1;2905/1;2859/1|
00000000|MMI|12.41|Atrophoderma vermiculatum|C0263429|[dsyn]|["AVA"-tx-11-"AVA"-noun-0,"AVA"-tx-8-"AVA"-noun-0,"AVA"-tx-6-"AVA"-noun-1,"AVA"-tx-4-"AVA"-noun-0]|TX|1552/3;1217/3;969/3;482/3|
00000000|MMI|12.37|Adverse Event Associated with Vascular|C1558950|[fndg]|["VASCULAR"-tx-42-"vascular"-adj-0,"VASCULAR"-tx-34-"vascular"-adj-0,"VASCULAR"-tx-24-"vascular"-adj-0,"VASCULAR"-tx-21-"vascular"-adj-0]|TX|5233/8;4524/8;3960/8;3566/8|
00000000|MMI|12.37|Vascular|C1801960|[qlco]|["Vascular"-tx-42-"vascular"-adj-0,"Vascular"-tx-34-"vascular"-adj-0,"Vascular"-tx-24-"vascular"-adj-0,"Vascular"-tx-21-"vascular"-adj-0]|TX|5233/8;4524/8;3960/8;3566/8|
00000000|MMI|12.27|Home environment|C0442519|[cnce]|["house"-tx-20-"house"-adj-0,"HOME"-tx-14-"home"-adj-0,"HOME"-tx-10-"home"-adj-0,"HOME"-tx-4-"Home"-noun-0]|TX|3416/5;1668/4;1380/4;316/4|
00000000|MMI|11.74|Woman|C0043210|[popg]|["female"-tx-16-"female"-noun-0]|TX|[2963/6],[3049/6]|M01.975
00000000|MMI|11.39|Chest|C0817096|[blor]|["CHEST"-tx-23-"CHEST"-noun-0]|TX|3714/5|A01.923.761;A02.835.232.904
00000000|MMI|11.39|Solomon Islands|C0037623|[geoa]|["BP"-tx-23-"BP"-noun-0]|TX|3664/2|Z01.639.760.590
00000000|MMI|11.34|General surgery specialty|C1274039|[bmod]|["Surgery"-tx-15-"surgery"-noun-0]|TX|2226/7|H02.403.810.300
00000000|MMI|11.33|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-42-"PLAN"-noun-0]|TX|5144/4|C10.228.140.744
00000000|MMI|11.20|Mongolia|C0026410|[geoa]|["MG"-tx-6-"MG"-noun-0]|TX|762/2|Z01.252.474.651
00000000|MMI|11.18|Foot|C0016504|[bpoc]|["FOOT"-tx-16-"foot"-noun-0]|TX|2861/4|A01.378.610.250
00000000|MMI|11.16|Osteomyelitis|C0029443|[dsyn]|["OSTEOMYELITIS"-tx-24-"osteomyelitis"-noun-0]|TX|4085/13|C01.539.160.495;C05.116.165.495
00000000|MMI|10.00|Followed by|C0332283|[tmco]|["Followed by"-tx-24-"followed by"-verb-0,"Followed by"-tx-16-"followed by"-verb-0,"follow"-tx-8-"follow"-verb-0]|TX|4134/11;2333/11;1133/6|
00000000|MMI|9.95|Complication Aspects|C1171258|[patf]|["complications"-tx-16-"Complications"-noun-0]|TX|2534/13|x.x.x
00000000|MMI|9.95|Dermatitis|C0011603|[dsyn]|["DERMATITIS"-tx-16-"dermatitis"-noun-0]|TX|2804/10|C17.800.174
00000000|MMI|9.95|Peripheral Vascular Diseases|C0085096|[dsyn]|["pvd"-tx-16-"PVD"-noun-0]|TX|3068/3|C14.907.617
00000000|MMI|9.68|ALYREF gene|C1425988|[gngm]|["REF"-tx-10-"ref"-noun-0,"REF"-tx-8-"ref"-noun-0,"REF"-tx-6-"ref"-noun-0]|TX|1270/3;1024/3;545/3|
00000000|MMI|9.68|Negation|C1518422|[ftcn]|["Not"-tx-32-"not"-adv-0,"Not"-tx-24-"not"-adv-0,"Not"-tx-16-"NOT"-adv-0]|TX|4474/3;3991/3;2896/3|
00000000|MMI|9.49|Admission activity|C0809949|[hlca]|["Admitted"-tx-24-"admitted"-verb-0,"Admitted"-tx-18-"admitted"-verb-0,"Admission"-tx-16-"Admission"-noun-0]|TX|4009/8;3273/8;2466/9|
00000000|MMI|9.42|seen|C0205397|[qlco]|["Seen"-tx-34-"Seen"-verb-0,"Seen"-tx-24-"Seen"-verb-0,"Seen"-tx-20-"seen"-verb-0]|TX|4516/4;3952/4;3429/4|
00000000|MMI|9.38|Ulceration|C3887532|[patf]|["ULCER"-tx-23-"ulcer"-noun-0,"ULCER"-tx-21-"ulcer"-noun-0,"Ulceration"-tx-16-"ulceration"-noun-0]|TX|3908/5;3485/5;2982/10|
00000000|MMI|9.31|+5|C0728893|[qnco]|["+5"-tx-39-"5"-integer-0,"+5"-tx-24-"5"-fraction-0,"+5"-tx-6-"5"-integer-0]|TX|4754/1;4052/1;760/1|
00000000|MMI|9.31|>5|C0439084|[qnco]|[">5"-tx-39-"5"-integer-0,">5"-tx-24-"5"-fraction-0,">5"-tx-6-"5"-integer-0]|TX|4754/1;4052/1;760/1|
00000000|MMI|9.30|Beginning|C0439659|[tmco]|["Start"-tx-31-"starting"-adj-0,"Start"-tx-14-"Starting"-adj-0,"Start"-tx-6-"Starting"-verb-0]|TX|4423/8;1741/8;772/8|
00000000|MMI|9.18|Plain x-ray|C1306645|[diap]|["Plain film"-tx-29-"plain film"-noun-0,"Plain film"-tx-28-"plain films"-noun-0,"Plain film"-tx-24-"plain films"-noun-0]|TX|4338/10;4274/11;4063/11|
00000000|MMI|9.15|Code|C0805701|[inpr]|["CODE"-tx-42-"CODE"-noun-0,"CODE"-tx-4-"CODE"-noun-0,"CODE"-tx-4-"code"-noun-0]|TX|4868/4;280/4;298/4|
00000000|MMI|9.15|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-42-"CODE"-noun-0,"Code"-tx-4-"CODE"-noun-0,"Code"-tx-4-"code"-noun-0]|TX|4868/4;280/4;298/4|
00000000|MMI|9.02|Baseline|C1442488|[qnco]|["Baseline"-tx-41-"baseline"-noun-0,"Baseline"-tx-37-"Baseline"-noun-0]|TX|4845/8;4680/8|
00000000|MMI|9.02|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-16-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-16-"DIAGNOSIS"-noun-1]|TX|[2374/9],[2498/9];[2374/9],[2498/9]|E01
00000000|MMI|9.02|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-16-"DIAGNOSIS"-noun-0]|TX|[2374/9],[2498/9]|
00000000|MMI|9.02|Edema:Finding:Point in time:^Patient:Ordinal|C1717255|[clna]|["Edema"-tx-23-"edema"-noun-0,"Edema"-tx-16-"edema"-noun-0]|TX|3933/5;2627/5|
00000000|MMI|9.02|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-16-"obesity"-noun-0]|TX|[2654/7],[2664/7]|
00000000|MMI|9.02|Requirement|C1514873|[ftcn]|["Required"-tx-34-"required"-verb-0,"Required"-tx-15-"Required"-verb-0]|TX|4560/8;1904/8|
00000000|MMI|9.02|amputated|C0231447|[fndg]|["Amputated"-tx-23-"amputated"-verb-0,"Amputated"-tx-17-"amputated"-verb-0]|TX|3839/9;3202/9|
00000000|MMI|9.02|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-43-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5359/6;49/6|
00000000|MMI|8.65|Abdomen|C0000726|[blor]|["abd"-tx-23-"ABD"-noun-0]|TX|3781/3|A01.923.047
00000000|MMI|8.65|Cyanosis|C0010520|[sosy]|["CYANOSIS"-tx-34-"cyanosis"-noun-0]|TX|4506/8|C23.888.248
00000000|MMI|8.65|Disease Management|C0376636|[hlca]|["management"-tx-22-"management"-noun-0]|TX|3623/10|N04.590.607
00000000|MMI|8.59|Food|C0016452|[food]|["FOODS"-tx-6-"foods"-noun-0]|TX|904/5|G07.203.300;J02.500
00000000|MMI|8.55|Amputation|C0002688|[topp]|["AMPUTATION"-tx-17-"amputation"-noun-0]|TX|3241/10|E04.555.080
00000000|MMI|8.55|Historical aspects qualifier|C0019665|[ftcn]|["history"-tx-16-"history"-noun-0]|TX|3128/7|x.x.x
00000000|MMI|8.47|Erythema|C0041834|[dsyn]|["Redness"-tx-16-"redness"-noun-0]|TX|2993/7|C17.800.229
00000000|MMI|8.46|Nonprofit Organizations|C0029247|[orgt]|["NPO"-tx-4-"NPO"-noun-0]|TX|376/3|N03.540.630
00000000|MMI|8.45|Communicable Diseases|C0009450|[dsyn]|["Infectious Disease"-tx-14-"infectious disease"-noun-0]|TX|1823/18|C01.539.221
00000000|MMI|8.45|Powder dose form|C0032861|[bodm]|["POWDER"-tx-14-"POWDER"-noun-0]|TX|1695/6|D26.255.779
00000000|MMI|8.45|Neurogenic arthropathy|C0003892|[dsyn]|["CHARCOT JOINT"-tx-23-"charcot joint"-noun-0]|TX|3858/13|C05.550.186
00000000|MMI|6.66|4+ Answer to question|C3838679|[fndg]|["4+"-tx-38-"4"-integer-0,"4+"-tx-17-"4"-fraction-0]|TX|4707/1;3212/1|
00000000|MMI|6.66|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-24-"PROCEDURES"-noun-0,"PROCEDURES"-tx-16-"PROCEDURES"-noun-0]|TX|4040/10;2832/10|
00000000|MMI|6.66|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-24-"PROCEDURES"-noun-0,"Procedures"-tx-16-"PROCEDURES"-noun-0]|TX|4040/10;2832/10|
00000000|MMI|6.66|Status|C0449438|[qlco]|["Status"-tx-23-"STATUS"-noun-0,"Status"-tx-4-"STATUS"-noun-0]|TX|3639/6;285/6|
00000000|MMI|6.58|Injury wounds|C0043250|[inpo]|["WOUND"-tx-42-"wound"-noun-0,"WOUND"-tx-32-"wound"-noun-0]|TX|5061/5;4458/5|
00000000|MMI|6.58|Traumatic injury|C3263723|[inpo]|["Wound"-tx-42-"wound"-noun-0,"Wound"-tx-32-"wound"-noun-0]|TX|5061/5;4458/5|
00000000|MMI|6.49|Diabetic foot ulcer|C1456868|[dsyn]|["Diabetic foot ulcers"-tx-26-"ulcer diabetic foot"-noun-0,"Diabetic foot ulcer"-tx-16-"Diabetic foot ulcer"-noun-0]|TX|4188/5,4196/13;3014/19|
00000000|MMI|6.43|Negative - answer|C3853545|[qlco]|["NEG"-tx-28-"neg"-noun-0,"NEG"-tx-24-"neg"-noun-0]|TX|4318/3;4077/3|
00000000|MMI|6.40|Basal Diet|C2983588|[food]|["DIET"-tx-39-"diet"-noun-0,"DIET"-tx-15-"DIET"-noun-0]|TX|4738/4;2132/4|
00000000|MMI|6.40|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-39-"diet"-noun-0,"Diet"-tx-15-"DIET"-noun-0]|TX|4738/4;2132/4|
00000000|MMI|6.40|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-39-"diet"-noun-0,"DIET"-tx-15-"DIET"-noun-0]|TX|4738/4;2132/4|
00000000|MMI|6.31|Present|C0150312|[qnco]|["Present"-tx-23-"present"-adj-0,"Found"-tx-21-"found"-verb-0]|TX|3816/7;3495/5|
00000000|MMI|6.30|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-36-"3"-integer-0,"3+"-tx-6-"3"-integer-0]|TX|4662/1;837/1|
00000000|MMI|6.30|3+ Score|C2827736|[qnco]|["3+"-tx-36-"3"-integer-0,"3+"-tx-6-"3"-integer-0]|TX|4662/1;837/1|
00000000|MMI|6.30|3+ Score, WHO|C2981702|[clas]|["3+"-tx-36-"3"-integer-0,"3+"-tx-6-"3"-integer-0]|TX|4662/1;837/1|
00000000|MMI|6.30|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-36-"3"-integer-0,"<3"-tx-6-"3"-integer-0]|TX|4662/1;837/1|
00000000|MMI|6.28|Summary (document)|C1706244|[inpr]|["Summary"-tx-42-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|5262/7;220/7|
00000000|MMI|6.28|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-42-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|5262/7;220/7|
00000000|MMI|6.25|Female Phenotype|C1705498|[qlco]|["Female"-tx-16-"female"-noun-0]|TX|[2963/6],[3049/6]|
00000000|MMI|6.25|Female, Self-Report|C1705497|[qlco]|["Female"-tx-16-"female"-noun-0]|TX|[2963/6],[3049/6]|
00000000|MMI|6.24|Entire bone (organ)|C1266908|[bpoc]|["Bone, NOS"-tx-32-"bone"-noun-0,"Bone, NOS"-tx-21-"bone"-noun-0]|TX|4487/4;3514/4|
00000000|MMI|6.24|Entire bony skeleton|C1266909|[bdsy]|["Bone"-tx-32-"bone"-noun-0,"Bone"-tx-21-"bone"-noun-0]|TX|4487/4;3514/4|
00000000|MMI|6.24|Skeletal bone|C0262950|[bpoc]|["BONE"-tx-32-"bone"-noun-0,"BONE"-tx-21-"bone"-noun-0]|TX|4487/4;3514/4|
00000000|MMI|6.23|Condition|C0348080|[qlco]|["Condition"-tx-42-"CONDITION"-noun-0,"Condition"-tx-16-"Conditions"-noun-0]|TX|5120/9;2508/10|
00000000|MMI|6.23|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-42-"CONDITION"-noun-0,"Condition"-tx-16-"Conditions"-noun-0]|TX|5120/9;2508/10|
00000000|MMI|6.23|Logical Condition|C1705253|[cnce]|["Condition"-tx-42-"CONDITION"-noun-0,"Condition"-tx-16-"Conditions"-noun-0]|TX|5120/9;2508/10|
00000000|MMI|6.18|Drainage procedure|C0013103|[topp]|["drain"-tx-23-"draining"-verb-0]|TX|3899/8|E02.309;E04.237
00000000|MMI|6.16|20%|C3842589|[fndg]|["20%"-tx-15-"20"-integer-0,"20%"-tx-6-"20"-integer-0]|TX|1957/2;791/2|
00000000|MMI|6.15|Discontinued|C1444662|[fndg]|["D/C"-tx-31-"D/c"-noun-0,"D/C"-tx-1-"D/C"-noun-1]|TX|4401/3;191/3|
00000000|MMI|6.15|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-31-"D/c"-noun-0,"D.C."-tx-1-"D/C"-noun-0]|TX|4401/3;191/3|
00000000|MMI|6.15|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-43-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|5332/2;152/2|
00000000|MMI|6.11|Out (direction)|C0439787|[spco]|["Out"-tx-35-"out"-adv-0,"Out"-tx-19-"out"-adv-0]|TX|4587/3;3395/3|
00000000|MMI|6.11|Removed|C0849355|[qlco]|["Out"-tx-35-"out"-adv-0,"Out"-tx-19-"out"-adv-0]|TX|4587/3;3395/3|
00000000|MMI|6.10|Cyanotic|C0332580|[ftcn]|["Cyanotic"-tx-24-"cyanotic"-adj-0,"Cyanotic"-tx-21-"cyanotic"-adj-0]|TX|3995/8;3542/8|
00000000|MMI|6.09|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-16-"RESUME"-noun-0,"Resume"-tx-15-"Resume"-noun-0]|TX|2926/6;2164/6|
00000000|MMI|6.09|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-16-"RESUME"-noun-0,"Resume"-tx-15-"Resume"-noun-0]|TX|2926/6;2164/6|
00000000|MMI|6.09|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-16-"RESUME"-noun-0,"resume"-tx-15-"Resume"-noun-0]|TX|2926/6;2164/6|
00000000|MMI|6.08|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-42-"Dr"-noun-0,"DR"-tx-24-"Dr"-noun-0]|TX|4936/2;4146/2|
00000000|MMI|6.08|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-42-"Dr"-noun-0,"DR"-tx-24-"Dr"-noun-0]|TX|4936/2;4146/2|
00000000|MMI|6.08|Doctor - Title|C2348314|[cnce]|["Dr."-tx-42-"Dr"-noun-0,"Dr."-tx-24-"Dr"-noun-0]|TX|4936/2;4146/2|
00000000|MMI|6.05|High|C0205250|[qlco]|["Elevated"-tx-37-"Elevated"-adj-0,"High"-tx-6-"high"-adj-0]|TX|4667/8;878/4|
00000000|MMI|6.04|Alert|C3665546|[ftcn]|["Alert"-tx-15-"Alert"-noun-0,"Alert"-tx-11-"Alert"-adj-0]|TX|2003/5;1492/5|
00000000|MMI|6.04|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-15-"Alert"-noun-0,"Alert"-tx-11-"Alert"-adj-0]|TX|2003/5;1492/5|
00000000|MMI|6.04|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-15-"Alert"-noun-0,"ALERT"-tx-11-"Alert"-adj-0]|TX|2003/5;1492/5|
00000000|MMI|6.04|Full|C0443225|[qlco]|["Full"-tx-42-"FULL"-adj-0,"Full"-tx-4-"Full"-adj-0]|TX|4863/4;293/4|
00000000|MMI|6.03|Further|C1517331|[spco]|["Further"-tx-35-"further"-adj-0,"Further"-tx-22-"further"-adj-0]|TX|4641/7;3615/7|
00000000|MMI|6.03|Tests (qualifier value)|C0392366|[inpr]|["testing"-tx-35-"testing"-noun-0,"Tests"-tx-24-"TESTS"-noun-0]|TX|4649/7;4034/5|
00000000|MMI|6.01|60%|C3842585|[fndg]|["60%"-tx-16-"60"-integer-0]|TX|[2957/2],[3043/2]|
00000000|MMI|6.01|CDR2 gene|C1413296|[gngm]|["Yo"-tx-16-"YO"-noun-0]|TX|[2960/2],[3046/2]|
00000000|MMI|6.00|TMPO wt Allele|C3541334|[gngm]|["TP"-tx-14-"TP"-noun-0,"TP"-tx-6-"TP"-noun-0]|TX|1710/2;676/2|
00000000|MMI|6.00|Topical surface|C0332237|[spco]|["Topical"-tx-14-"TOPICAL"-adj-0,"Topical"-tx-6-"TOPICAL"-adj-0]|TX|1702/7;668/7|
00000000|MMI|6.00|At|C1516077|[spco]|["At"-tx-14-"at"-adj-0,"At"-tx-10-"at"-adj-0]|TX|1665/2;1377/2|
00000000|MMI|6.00|GATM wt Allele|C4049625|[gngm]|["AT"-tx-14-"at"-adj-0,"AT"-tx-10-"at"-adj-0]|TX|1665/2;1377/2|
00000000|MMI|5.92|Neck|C0027530|[blor]|["NECK"-tx-23-"NECK"-noun-0]|TX|3701/4|A01.598
00000000|MMI|5.84|Medicine|C0025118|[bmod]|["Medicine"-tx-24-"medicine"-noun-0]|TX|4021/8|H02.403
00000000|MMI|5.82|Debridement|C0011079|[topp]|["Debridement"-tx-16-"debridement"-noun-0]|TX|2844/11|E04.176
00000000|MMI|5.81|History|C0019664|[ocdi]|["History"-tx-16-"history"-noun-0]|TX|3128/7|K01.400
00000000|MMI|5.70|Alkalies|C0002055|[inch]|["base"-tx-23-"base"-noun-0]|TX|3764/4|D01.045
00000000|MMI|4.49|+2|C0740116|[qnco]|["+2"-tx-33-"2"-integer-0]|TX|4497/1|
00000000|MMI|4.49|1+|C3816745|[fndg]|["1+"-tx-25-"1"-integer-0]|TX|4179/1|
00000000|MMI|4.49|1+ Score|C2827734|[qnco]|["1+"-tx-25-"1"-integer-0]|TX|4179/1|
00000000|MMI|4.49|1+ Score, WHO|C2981698|[clas]|["1+"-tx-25-"1"-integer-0]|TX|4179/1|
00000000|MMI|4.49|2+|C3833492|[fndg]|["2+"-tx-33-"2"-integer-0]|TX|4497/1|
00000000|MMI|4.49|2+ Score|C2827735|[qnco]|["2+"-tx-33-"2"-integer-0]|TX|4497/1|
00000000|MMI|4.49|2+ Score, WHO|C2981700|[clas]|["2+"-tx-33-"2"-integer-0]|TX|4497/1|
00000000|MMI|4.49|5 Days|C1442466|[tmco]|["5 Days"-tx-19-"5 days"-noun-0]|TX|3359/6|
00000000|MMI|4.49|7 days|C1547085|[tmco]|["7 days"-tx-15-"7 days"-noun-0]|TX|2311/6|
00000000|MMI|4.49|AMBP gene|C1412376|[gngm]|["UTI"-tx-16-"uti"-noun-0]|TX|2752/3|
00000000|MMI|4.49|Act Relationship Subset - previous|C1552607|[tmco]|["previous"-tx-8-"Previous"-adj-0]|TX|1144/8|
00000000|MMI|4.49|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-16-"OPERATIONS"-noun-0]|TX|2817/10|
00000000|MMI|4.49|Affecting|C0392760|[ftcn]|["Affecting"-tx-16-"affecting"-verb-0]|TX|2550/9|
00000000|MMI|4.49|Approximate|C0332232|[qlco]|["Approximate"-tx-15-"approximate"-adj-0]|TX|1915/11|
00000000|MMI|4.49|Arikaree language|C1555622|[lang]|["Ris"-tx-39-"RISS"-noun-0]|TX|4745/4|
00000000|MMI|4.49|C-Circle|C3538933|[celc]|["CC"-tx-16-"CC"-noun-0]|TX|2974/2|
00000000|MMI|4.49|CDISC Events Class|C3541888|[clas]|["EVENTS"-tx-24-"EVENTS"-noun-0]|TX|3944/6|
00000000|MMI|4.49|Changed status|C0443172|[qnco]|["changes"-tx-42-"changes"-verb-0]|TX|5067/7|
00000000|MMI|4.49|Changing|C0392747|[ftcn]|["changes"-tx-42-"changes"-verb-0]|TX|5067/7|
00000000|MMI|4.49|Complication|C0009566|[patf]|["Complications"-tx-16-"Complications"-noun-0]|TX|2534/13|
00000000|MMI|4.49|Continuous|C0549178|[idcn]|["Continue"-tx-42-"continue"-verb-0]|TX|5035/8|
00000000|MMI|4.49|Delta (difference)|C1705241|[qnco]|["Change"-tx-42-"changes"-verb-0]|TX|5067/7|
00000000|MMI|4.49|Device Exposure Domain|C3538936|[idcn]|["DX"-tx-16-"DX"-noun-0]|TX|3010/2|
00000000|MMI|4.49|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.49|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-3-"PH.D"-noun-0]|TX|274/4|
00000000|MMI|4.49|Dry|C0205222|[qlco]|["Dry"-tx-42-"dry"-verb-0]|TX|5057/3|
00000000|MMI|4.49|Dryness (characteristic)|C1512080|[qlco]|["Dry"-tx-42-"dry"-verb-0]|TX|5057/3|
00000000|MMI|4.49|Event|C0441471|[evnt]|["Events"-tx-24-"EVENTS"-noun-0]|TX|3944/6|
00000000|MMI|4.49|Follow|C1719822|[inpr]|["Follow"-tx-8-"follow"-verb-0]|TX|1133/6|
00000000|MMI|4.49|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-10-"grapefruit"-noun-0]|TX|1450/10|
00000000|MMI|4.49|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-10-"grapefruit"-noun-0]|TX|1450/10|
00000000|MMI|4.49|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-10-"grapefruit"-noun-0]|TX|1450/10|
00000000|MMI|4.49|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-16-"OPERATIONS"-noun-0]|TX|2817/10|
00000000|MMI|4.49|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-16-"hypertension"-noun-0]|TX|2612/12|
00000000|MMI|4.49|Hyrex Brand of Dimenhydrinate|C0720930|[orch,phsu]|["hydrate"-tx-37-"hydrate"-verb-0]|TX|4694/7|
00000000|MMI|4.49|Information|C1533716|[idcn]|["INFORMATION"-tx-8-"information"-noun-0]|TX|1162/11|
00000000|MMI|4.49|Involvement with|C1314939|[ftcn]|["Affecting"-tx-16-"affecting"-verb-0]|TX|2550/9|
00000000|MMI|4.49|Left|C0205091|[spco]|["Levo-"-tx-31-"levo"-adj-0]|TX|4414/4|
00000000|MMI|4.49|Moist|C0205381|[qlco]|["Wet"-tx-42-"wet"-verb-0]|TX|5050/3|
00000000|MMI|4.49|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|171/14|
00000000|MMI|4.49|PROBLEM LIST|C0552582|[inpr]|["PROBLEM LIST"-tx-25-"PROBLEM LIST"-noun-0]|TX|4162/12|
00000000|MMI|4.49|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|171/14|
00000000|MMI|4.49|Peripheral edema|C0085649|[fndg]|["Peripheral oedema"-tx-16-"peripheral edema"-noun-0]|TX|2635/16|
00000000|MMI|4.49|Previous|C0205156|[tmco]|["Previous"-tx-8-"Previous"-adj-0]|TX|1144/8|
00000000|MMI|4.49|RASL12 gene|C1428956|[gngm]|["RIS"-tx-39-"RISS"-noun-0]|TX|4745/4|
00000000|MMI|4.49|Radioisotope scan of bone|C0203668|[diap]|["Bone Scan"-tx-28-"Bone scan"-noun-0]|TX|4260/9|
00000000|MMI|4.49|Recommendation|C0034866|[idcn]|["Recommended"-tx-31-"recommended"-verb-0]|TX|4389/11|
00000000|MMI|4.49|Recurrent cellulitis|C0742020|[dsyn]|["Cellulitis, recurrent"-tx-16-"recurrent cellulitis"-noun-0]|TX|2674/20|
00000000|MMI|4.49|Recurrent urinary tract infection|C0262655|[dsyn]|["Urinary tract infection"-tx-16-"urinary tract infection"-noun-0]|TX|2758/23|
00000000|MMI|4.49|S prime|C2603362|[clna]|["S'"-tx-15-"("-noun-0]|TX|2209/1|
00000000|MMI|4.49|Views^W radionuclide Intravenous:Finding:Point in time:Bone:Narrative:Radnuc|C0882187|[clna]|["Bone Scan"-tx-28-"Bone scan"-noun-0]|TX|4260/9|
00000000|MMI|4.49|per second|C0565930|[qnco]|["/s"-tx-15-"("-noun-0]|TX|2209/1|
00000000|MMI|4.49|problem list - observation|C1553895|[inpr]|["problem list"-tx-25-"PROBLEM LIST"-noun-0]|TX|4162/12|
00000000|MMI|4.49|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-16-"TREATMENTS/PROCEDURES"-noun-0]|TX|2872/21|
00000000|MMI|3.57|Known allergy|C3845888|[fndg]|["Known allergy"-tx-16-"Known Allergies"-noun-1]|TX|2352/15|
00000000|MMI|3.44|Appearance|C0700364|[qlco]|["APPEAR"-tx-21-"appeared"-verb-0]|TX|3533/8|
00000000|MMI|3.44|Drain device|C0180499|[medd]|["DRAIN"-tx-23-"draining"-verb-0]|TX|3899/8|
00000000|MMI|3.28|Standard Time|C3641800|[tmco]|["Standard Time"-tx-6-"Standard Time"-noun-0]|TX|799/8,814/4|
00000000|MMI|3.25|Distance vision 6/12|C0442752|[fndg]|["6/12"-tx-1-"6/12"-fraction-0]|TX|16/4|
00000000|MMI|3.25|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-4-"DISCHARGE MEDICATIONS"-noun-0]|TX|321/21|
00000000|MMI|3.19|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-15-"ACTIVITY"-noun-0]|TX|2154/8|
00000000|MMI|3.19|ABD tumor staging notation|C0449202|[inpr]|["ABD"-tx-23-"ABD"-noun-0]|TX|3781/3|
00000000|MMI|3.19|Absence of Biallelic TCRgamma Deletion|C3811055|[comd]|["ABD"-tx-23-"ABD"-noun-1]|TX|3781/3|
00000000|MMI|3.19|Active|C0205177|[ftcn]|["Activity"-tx-15-"ACTIVITY"-noun-0]|TX|2154/8|
00000000|MMI|3.19|Activities|C0441655|[acty]|["ACTIVITY"-tx-15-"ACTIVITY"-noun-0]|TX|2154/8|
00000000|MMI|3.19|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-15-"ACTIVITY"-noun-1]|TX|2154/8|
00000000|MMI|3.19|Additional comments|C1830770|[fndg]|["Additional comments"-tx-42-"ADDITIONAL COMMENTS"-noun-0]|TX|4873/19|
00000000|MMI|3.19|Administration occupational activities|C0001554|[ocac]|["Management"-tx-22-"management"-noun-0]|TX|3623/10|
00000000|MMI|3.19|Anterior thoracic region|C1527391|[blor]|["Chest"-tx-23-"CHEST"-noun-0]|TX|3714/5|
00000000|MMI|3.19|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|233/9|
00000000|MMI|3.19|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|233/9|
00000000|MMI|3.19|CR2 wt Allele|C3539604|[gngm]|["CR"-tx-37-"CR"-noun-0]|TX|4676/2|
00000000|MMI|3.19|Creatinine measurement|C0201975|[lbpr]|["Cr"-tx-37-"CR"-noun-0]|TX|4676/2|
00000000|MMI|3.19|Entire neck|C1281592|[bpoc]|["Neck"-tx-23-"NECK"-noun-0]|TX|3701/4|
00000000|MMI|3.19|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-6-"gt"-noun-0]|TX|834/2|
00000000|MMI|3.19|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-15-"ACTIVITY"-noun-0]|TX|2154/8|
00000000|MMI|3.19|HP gene|C1415692|[gngm]|["Bp"-tx-23-"BP"-noun-0]|TX|3664/2|
00000000|MMI|3.19|HP wt Allele|C1708288|[gngm]|["BP"-tx-23-"BP"-noun-0]|TX|3664/2|
00000000|MMI|3.19|Intervention regimes|C1273869|[hlca]|["Intervention"-tx-34-"intervention"-noun-0]|TX|4547/12|
00000000|MMI|3.19|Lymphotoxin-Alpha, human|C3887647|[aapp,imft]|["LT"-tx-4-"lt"-noun-0]|TX|416/2|
00000000|MMI|3.19|Management Occupations|C3273539|[ocdi]|["Management"-tx-22-"management"-noun-0]|TX|3623/10|
00000000|MMI|3.19|Management procedure|C1273870|[ocac]|["Management"-tx-22-"management"-noun-0]|TX|3623/10|
00000000|MMI|3.19|NT5E wt Allele|C3889152|[gngm]|["NT"-tx-23-"NT"-noun-0]|TX|3793/2|
00000000|MMI|3.19|No treatment required for|C0332126|[qlco]|["NT"-tx-23-"NT"-noun-0]|TX|3793/2|
00000000|MMI|3.19|Nursing interventions|C0886296|[hlca]|["intervention"-tx-34-"intervention"-noun-0]|TX|4547/12|
00000000|MMI|3.19|Percent Activity|C0439167|[qnco]|["% Activity"-tx-15-"ACTIVITY"-noun-0]|TX|2154/8|
00000000|MMI|3.19|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-15-"ACTIVITY"-noun-0]|TX|2154/8|
00000000|MMI|3.19|Routine|C0205547|[qlco]|["Routine"-tx-6-"ROUTINE"-adj-0]|TX|781/7|
00000000|MMI|3.19|S1|C3715215|[fndg]|["S1"-tx-23-"S1"-noun-1]|TX|3745/2|
00000000|MMI|3.19|SSS|C0723181|[phsu]|["SSS"-tx-40-"SSS"-noun-0]|TX|4762/3|
00000000|MMI|3.19|Structure of left thigh|C0230426|[bpoc]|["LT"-tx-4-"lt"-noun-0]|TX|416/2|
00000000|MMI|3.19|Surgical and medical procedures|C1948041|[topp]|["Intervention"-tx-34-"intervention"-noun-0]|TX|4547/12|
00000000|MMI|3.19|Testicular Cancer Serum Markers Test Result S1|C3814877|[lbtr]|["S1"-tx-23-"S1"-noun-1]|TX|3745/2|
00000000|MMI|3.19|Tyrosine Nitration|C4050156|[moft]|["NT"-tx-23-"NT"-noun-0]|TX|3793/2|
00000000|MMI|3.19|dendritic spine neck|C3159206|[celc]|["neck"-tx-23-"NECK"-noun-0]|TX|3701/4|
00000000|MMI|3.18|Seen by vascular surgeon|C0583623|[fndg]|["Seen by vascular surgeon"-tx-35-"seen by vascular surgeon"-noun-0]|TX|4579/7,4594/16|
00000000|MMI|3.18|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-16-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2399/9,2419/9|
00000000|MMI|3.18|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-16-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|2399/9,2419/9|
00000000|MMI|3.16|Dose number|C1115464|[qnco]|["Dose number"-tx-15-"Number Doses"-noun-0]|TX|1888/6,1898/5|
00000000|MMI|3.16|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-15-"Number Doses"-noun-0]|TX|1888/6,1898/5|
00000000|MMI|3.16|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-16-"DISCHARGE DIAGNOSIS"-noun-1]|TX|2409/19|
00000000|MMI|3.15|Entered|C1521975|[qlco]|["Entered"-tx-42-"ENTERED"-verb-0]|TX|5270/7|
00000000|MMI|3.15|Treated with|C0332293|[topp]|["Treated with"-tx-19-"treated with"-verb-0]|TX|3332/12|
00000000|MMI|3.15|Allopathic & Osteopathic Physicians - Surgery|C3853799|[prog]|["Surgery"-tx-15-"surgery"-noun-0]|TX|2226/7|
00000000|MMI|3.15|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-23-"CV"-noun-0]|TX|3737/2|
00000000|MMI|3.15|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-16-"diabetes"-noun-0]|TX|2575/8|
00000000|MMI|3.15|Disposition|C0743223|[idcn]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|303/11|
00000000|MMI|3.15|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-4-"DISPOSITION"-noun-0]|TX|303/11|
00000000|MMI|3.15|GEN1 gene|C2239486|[gngm]|["Gen"-tx-23-"GEN"-noun-0]|TX|3692/3|
00000000|MMI|3.15|Operative Surgical Procedures|C0543467|[hlca]|["Surgery"-tx-15-"surgery"-noun-0]|TX|2226/7|E04
00000000|MMI|3.15|Surgery specialty|C0038894|[bmod]|["Surgery"-tx-15-"surgery"-noun-0]|TX|2226/7|
00000000|MMI|3.13|Every evening|C0585330|[tmco]|["QPM"-tx-6-"QPM"-noun-0]|TX|768/3|
00000000|MMI|3.13|Experimental Result|C2825142|[fndg]|["Result"-tx-29-"result"-noun-0]|TX|4349/6|
00000000|MMI|3.13|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-6-"QPM"-noun-0]|TX|768/3|
00000000|MMI|3.13|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-16-"pain"-noun-0]|TX|3001/4|
00000000|MMI|3.13|Planned|C1301732|[ftcn]|["Plan"-tx-42-"PLAN"-noun-0]|TX|5144/4|
00000000|MMI|3.13|Result|C1274040|[ftcn]|["Result"-tx-29-"result"-noun-0]|TX|4349/6|
00000000|MMI|3.13|Treatment Plan|C0599880|[inpr]|["Plan"-tx-42-"PLAN"-noun-0]|TX|5144/4|
00000000|MMI|3.13|What subject filter - Result|C1546471|[idcn]|["Result"-tx-29-"result"-noun-0]|TX|4349/6|
00000000|MMI|3.12|Secondary to|C0175668|[tmco]|["Secondary to"-tx-41-"secondary to"-adj-0]|TX|4824/12|
00000000|MMI|3.12|Dermatologist|C0259831|[prog]|["Dermatologist"-tx-21-"dermatologist"-noun-0]|TX|3467/13|
00000000|MMI|3.11|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|100/7|
00000000|MMI|3.11|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-6-"Instructions"-noun-0]|TX|682/12|
00000000|MMI|3.11|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|100/7|
00000000|MMI|3.11|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|100/7|
00000000|MMI|3.11|Chemical Probe|C2347609|[chvf]|["Probe"-tx-32-"probe"-verb-0]|TX|4478/5|
00000000|MMI|3.11|Chronic atrial fibrillation|C0694539|[dsyn]|["Chronic AF"-tx-16-"chronic AF"-noun-0]|TX|3074/10|
00000000|MMI|3.11|End|C0444930|[spco]|["End"-tx-43-"END"-noun-0]|TX|5342/3|
00000000|MMI|3.11|Extension|C0231448|[ftcn]|["Extend"-tx-21-"extend"-verb-0]|TX|3504/6|
00000000|MMI|3.11|Extent|C0439792|[spco]|["extend"-tx-21-"extend"-verb-0]|TX|3504/6|
00000000|MMI|3.11|Pharmaceutical Preparations|C0013227|[phsu]|["Medicine"-tx-24-"medicine"-noun-0]|TX|4021/8|D26
00000000|MMI|3.11|Probe Device Component|C3536729|[mnob]|["Probe"-tx-32-"probe"-verb-0]|TX|4478/5|
00000000|MMI|3.11|Probes|C0182400|[medd]|["PROBE"-tx-32-"probe"-verb-0]|TX|4478/5|
00000000|MMI|3.11|Responsible to|C1273518|[fndg]|["Responsible"-tx-16-"Responsible"-adj-1]|TX|2430/11|
00000000|MMI|3.11|Started|C1272689|[qlco]|["Started"-tx-27-"started"-verb-0]|TX|4233/7|
00000000|MMI|3.11|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-43-"END"-noun-0]|TX|5342/3|
00000000|MMI|3.11|ppm|C0439187|[qnco]|["PPM"-tx-40-"PPM"-noun-0]|TX|4776/3|
00000000|MMI|3.11|probe gene fragment|C1704681|[gngm]|["Probe"-tx-32-"probe"-verb-0]|TX|4478/5|
00000000|MMI|3.10|Today|C0310367|[antb,orch]|["Today"-tx-14-"Today"-noun-0]|TX|1750/5|
00000000|MMI|3.10|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-14-"Today"-noun-0]|TX|1750/5|
00000000|MMI|3.09|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|155/10|
00000000|MMI|3.09|Debridement by Maggots|C3245462|[topp]|["Debridement"-tx-16-"debridement"-noun-0]|TX|2844/11|
00000000|MMI|3.09|Send (transmission)|C1519246|[ftcn]|["Sent"-tx-22-"sent"-verb-0]|TX|3594/4|
00000000|MMI|3.09|Surg|C3541227|[tmco]|["Surg"-tx-24-"surg"-noun-0]|TX|3969/4|
00000000|MMI|3.09|Unasyn|C0147814|[antb,orch]|["Unasyn"-tx-19-"unasyn"-noun-0]|TX|3348/6|
00000000|MMI|3.08|Amputated structure (morphologic abnormality)|C0332840|[acab]|["Amputation"-tx-17-"amputation"-noun-0]|TX|3241/10|
00000000|MMI|3.08|Amputation Specimen Code|C1546539|[inpr]|["Amputation"-tx-17-"amputation"-noun-0]|TX|3241/10|
00000000|MMI|3.08|Antibiotic throat preparations|C3540706|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|
00000000|MMI|3.08|Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C3540707|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|
00000000|MMI|3.08|Antibiotics for systemic use|C3540704|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|
00000000|MMI|3.08|Antibiotics, Gynecological|C3540708|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|
00000000|MMI|3.08|Antibiotics, ophthalmologic|C3540710|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|
00000000|MMI|3.08|Antifungal Antibiotics, Topical|C3540705|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|
00000000|MMI|3.08|Concept History|C1705255|[cnce]|["History"-tx-16-"history"-noun-0]|TX|3128/7|
00000000|MMI|3.08|History of present illness|C0262512|[orga]|["History, NOS"-tx-16-"history"-noun-0]|TX|3128/7|
00000000|MMI|3.08|History of previous events|C2004062|[fndg]|["History"-tx-16-"history"-noun-0]|TX|3128/7|
00000000|MMI|3.08|Medical History|C0262926|[fndg]|["History"-tx-16-"history"-noun-0]|TX|3128/7|
00000000|MMI|3.08|antibiotics, intestinal|C3540709|[antb]|["Antibiotics"-tx-42-"antibiotics"-noun-0]|TX|5084/11|
00000000|MMI|3.08|Switch Device Component|C1707719|[mnob]|["Switch"-tx-19-"switched"-verb-0]|TX|3370/8|
00000000|MMI|3.08|Approval (document)|C2346845|[inpr]|["Approval"-tx-14-"approval"-noun-0]|TX|1842/8|
00000000|MMI|3.08|Approved|C0205540|[qlco]|["Approval"-tx-14-"approval"-noun-0]|TX|1842/8|
00000000|MMI|3.08|Letter of Authorization|C2697909|[rnlw]|["Approval"-tx-14-"approval"-noun-0]|TX|1842/8|
00000000|MMI|3.08|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|204/4|
00000000|MMI|3.06|Glyburide 2.5 MG|C0986276|[clnd]|["Glyburide 2.5 MG"-tx-4-"GLYBURIDE 2.5 MG"-noun-0]|TX|344/16|
00000000|MMI|3.05|lower extremity rash|C0240250|[fndg]|["LOWER EXTREMITY RASH"-tx-6-"lower extremity rash"-noun-0]|TX|710/20|
00000000|MMI|3.03|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-39-"ADA"-noun-0]|TX|4734/3|
00000000|MMI|3.03|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AF"-tx-40-"AF"-noun-0]|TX|4759/2|
00000000|MMI|3.03|Bowel sounds|C0232693|[fndg]|["Bowel sounds"-tx-23-"bowel sounds"-noun-1]|TX|3803/12|
00000000|MMI|3.03|Causing|C0678227|[ftcn]|["Causing"-tx-16-"Causing"-adj-0]|TX|2458/7|
00000000|MMI|3.03|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Elevated|C3163633|[qlco]|["Elevated"-tx-37-"Elevated"-adj-0]|TX|4667/8|
00000000|MMI|3.03|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|33/5|
00000000|MMI|3.03|Genus Ada|C1060325|[plnt]|["Ada"-tx-39-"ADA"-noun-0]|TX|4734/3|
00000000|MMI|3.03|Jugular venous engorgement|C0425687|[fndg]|["JVD"-tx-23-"JVD"-noun-1]|TX|3710/3|
00000000|MMI|3.03|Laboratory Procedures|C0022885|[lbpr]|["Tests"-tx-24-"TESTS"-noun-0]|TX|4034/5|
00000000|MMI|3.03|Lisinopril 10 MG|C0987217|[clnd]|["Lisinopril 10 MG"-tx-4-"LISINOPRIL 10 MG"-noun-0]|TX|380/16|
00000000|MMI|3.03|PSMD4 wt Allele|C4049859|[gngm]|["AF"-tx-40-"AF"-noun-0]|TX|4759/2|
00000000|MMI|3.03|SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS SYNDROME|C3542022|[dsyn]|["SOFT"-tx-23-"soft"-adj-1]|TX|3786/4|
00000000|MMI|3.03|Soft|C0205358|[qlco]|["Soft"-tx-23-"soft"-adj-0]|TX|3786/4|
00000000|MMI|3.03|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|229/3|
00000000|MMI|3.03|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|229/3|
00000000|MMI|3.03|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-42-"dictated"-adj-0]|TX|5253/8|
00000000|MMI|3.03|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-42-"dictated"-adj-0]|TX|5253/8|
00000000|MMI|3.03|emergent|C0750573|[idcn]|["emergent"-tx-34-"emergent"-adj-0]|TX|4538/8|
00000000|MMI|3.03|5/5|C0450380|[qnco]|["5/5"-tx-24-"5 5"-fraction-0]|TX|4113/1,4121/1|
00000000|MMI|3.02|mg/mg|C1319635|[qnco]|["mg/mg"-tx-15-"MG MG"-noun-0]|TX|1960/2,1994/2|
00000000|MMI|3.02|Vitamin K Drug Class|C3714648|[phsu,vita]|["VITAMIN K"-tx-6-"Vitamin-K"-noun-0]|TX|883/9|
00000000|MMI|3.02|Vitamin K [EPC]|C2936884|[phsu]|["Vitamin K"-tx-6-"Vitamin-K"-noun-0]|TX|883/9|
00000000|MMI|3.02|Vitamin K containing hemostatics|C3541380|[orch,phsu,vita]|["Vitamin K"-tx-6-"Vitamin-K"-noun-0]|TX|883/9|
00000000|MMI|3.01|Restricted|C0443288|[ftcn]|["Restriction"-tx-15-"Restrictions"-noun-0]|TX|2141/12|
00000000|MMI|3.01|100%|C3817553|[qnco]|["100%"-tx-23-"100"-percentage-0]|TX|3685/3|
00000000|MMI|3.01|Administration procedure|C1533734|[topp]|["Treatment"-tx-16-"Treatment"-noun-0]|TX|2560/9|
00000000|MMI|3.01|Axial R|C3538806|[spco]|["Ra"-tx-23-"RA"-noun-0]|TX|3689/2|
00000000|MMI|3.01|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-16-"Treatment"-noun-0]|TX|2560/9|
00000000|MMI|3.01|Cancer/Testis Antigen|C3813556|[aapp]|["CTA"-tx-23-"CTA"-noun-0]|TX|3721/3|
00000000|MMI|3.01|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-24-"ED"-noun-0]|TX|3977/2|
00000000|MMI|3.01|Fifth|C0205439|[qnco]|["Fifth"-tx-23-"fifth"-noun-0]|TX|3914/5|
00000000|MMI|3.01|House (environment)|C2003847|[mnob]|["House"-tx-20-"house"-adj-0]|TX|3416/5|
00000000|MMI|3.01|PCYT1A wt Allele|C3540513|[gngm]|["CTA"-tx-23-"CTA"-noun-0]|TX|3721/3|
00000000|MMI|3.01|Regular exercise (observable entity)|C0582191|[dora]|["Regular exercise"-tx-15-"regular exercise"-noun-0]|TX|2171/16|
00000000|MMI|3.01|Right arm|C4048756|[bpoc]|["RA"-tx-23-"RA"-noun-0]|TX|3689/2|
00000000|MMI|3.01|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-16-"Treatment"-noun-0]|TX|2560/9|E02
00000000|MMI|3.01|Treating|C1522326|[ftcn]|["Treatment"-tx-16-"Treatment"-noun-0]|TX|2560/9|
00000000|MMI|3.01|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-16-"Treatment"-noun-0]|TX|2560/9|
00000000|MMI|3.01|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-16-"Treatment"-noun-0]|TX|2560/9|
00000000|MMI|3.01|As Needed|C1883728|[qlco]|["As Needed"-tx-6-"as needed"-adj-0]|TX|652/9|
00000000|MMI|3.01|PRN (schedule frequency)|C1879745|[tmco]|["As needed"-tx-6-"as needed"-adj-0]|TX|652/9|
00000000|MMI|3.00|Simvastatin 20 MG|C0989915|[clnd]|["Simvastatin 20 MG"-tx-10-"SIMVASTATIN 20 MG"-noun-0]|TX|1385/17|
00000000|MMI|3.00|97|C0439073|[inpr]|["97"-tx-23-"97"-real_number-0]|TX|3653/2|
00000000|MMI|3.00|>97|C0439082|[qnco]|[">97"-tx-23-"97"-real_number-0]|TX|3653/2|
00000000|MMI|3.00|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-6-"MG"-noun-0]|TX|762/2|
00000000|MMI|3.00|Milligram percent|C1960952|[qnco]|["mg %"-tx-6-"MG"-noun-0]|TX|762/2|
00000000|MMI|3.00|New|C0205314|[qlco]|["NEW"-tx-29-"new"-adj-0]|TX|4334/3|
00000000|MMI|3.00|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-42-"Stable"-adj-0]|TX|5131/6|
00000000|MMI|3.00|Presentation|C0449450|[idcn]|["Present"-tx-23-"present"-adj-0]|TX|3816/7|
00000000|MMI|3.00|Red color|C1260956|[qlco]|["redness"-tx-16-"redness"-noun-0]|TX|2993/7|
00000000|MMI|3.00|Redness|C0332575|[fndg]|["Redness"-tx-16-"redness"-noun-0]|TX|2993/7|
00000000|MMI|3.00|Stable status|C0205360|[qlco]|["STABLE"-tx-42-"Stable"-adj-0]|TX|5131/6|
00000000|MMI|3.00|T prime|C2603360|[clna]|["T'"-tx-23-"T"-adj-0]|TX|3651/1|
00000000|MMI|3.00|Ulceration Adverse Event|C1963256|[fndg]|["Ulceration"-tx-16-"ulceration"-noun-0]|TX|2982/10|
00000000|MMI|3.00|mg/dL|C0439269|[qnco]|["mg%"-tx-6-"MG"-noun-0]|TX|762/2|
00000000|MMI|3.00|Abnormally high|C1299351|[qlco]|["High"-tx-6-"high"-adj-0]|TX|878/4|
00000000|MMI|3.00|Bilateral|C0238767|[spco]|["BILATERAL"-tx-6-"bilateral"-adj-0]|TX|700/9|
00000000|MMI|3.00|Contain (action)|C2700400|[acty]|["Containing"-tx-6-"containing"-adj-0]|TX|893/10|
00000000|MMI|3.00|Containing (qualifier)|C0332256|[ftcn]|["Containing"-tx-6-"containing"-adj-0]|TX|893/10|
00000000|MMI|3.00|High Mitosis-Karyorrhexis Index|C3889660|[qnco]|["High"-tx-6-"high"-adj-0]|TX|878/4|
00000000|MMI|3.00|Primary|C0205225|[qlco]|["Principal"-tx-16-"PRINCIPAL"-adj-0]|TX|2399/9|
00000000|MMI|3.00|Teaching principal|C0401925|[prog]|["Principal"-tx-16-"PRINCIPAL"-adj-0]|TX|2399/9|
00000000|MMI|3.00|Value Above Reference Range|C2700149|[inpr]|["HIGH"-tx-6-"high"-adj-0]|TX|878/4|
00000000|MMI|3.00|high - ActExposureLevelCode|C3887512|[idcn]|["high"-tx-6-"high"-adj-0]|TX|878/4|
00000000|MMI|3.00|saw (device)|C0183089|[medd]|["SAW"-tx-21-"saw"-noun-0]|TX|3463/3|
00000000|MMI|3.00|linezolid 600 MG|C1127473|[clnd]|["linezolid 600 MG"-tx-14-"LINEZOLID 600 MG"-noun-0]|TX|1717/16|
00000000|MMI|2.99|NPO - Nothing by mouth|C0419179|[topp]|["NPO"-tx-4-"NPO"-noun-0]|TX|376/3|
00000000|MMI|2.99|Sarna|C1519185|[orch,phsu]|["Sarna"-tx-6-"SARNA"-noun-0]|TX|662/5|
00000000|MMI|2.99|Infectious Disease Pathway|C3714515|[ftcn]|["Infectious Disease"-tx-14-"infectious disease"-noun-0]|TX|1823/18|
00000000|MMI|2.99|Room of building - Study|C0557651|[mnob]|["Study"-tx-16-"Study"-noun-0]|TX|2448/5|
00000000|MMI|2.99|Study|C2603343|[resa]|["Study"-tx-16-"Study"-noun-0]|TX|2448/5|
00000000|MMI|2.99|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-10-"QHS"-noun-0]|TX|1406/3|
00000000|MMI|2.99|powder physical state|C1382110|[sbst]|["Powder"-tx-14-"POWDER"-noun-0]|TX|1695/6|
00000000|MMI|2.98|Hospital course|C0489547|[fndg]|["Hospital course"-tx-16-"HOSPITAL COURSE"-noun-1]|TX|2936/15|
00000000|MMI|2.98|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-16-"HOSPITAL COURSE"-noun-0]|TX|2936/15|
00000000|MMI|2.98|Immediate Release Dosage Form|C1708470|[bodm]|["Immediate Release"-tx-6-"IMMEDIATE RELEASE"-noun-0]|TX|522/17|
00000000|MMI|2.98|Orthopedic surgeon|C0334891|[prog]|["Orthopedic surgeon"-tx-42-"orthopedic surgeon"-noun-0]|TX|4984/18|
00000000|MMI|2.98|Radiography of foot|C0203287|[diap]|["Foot X-ray"-tx-16-"foot xray"-noun-0]|TX|2910/9|
00000000|MMI|2.98|Views:Finding:Point in time:Foot:Narrative:XR|C0882531|[clna]|["Foot X-ray"-tx-16-"foot xray"-noun-0]|TX|2910/9|
00000000|MMI|2.98|Entire foot|C1281587|[bpoc]|["Foot"-tx-16-"foot"-noun-0]|TX|2861/4|
00000000|MMI|2.98|Feet, unit of measurement|C0347981|[qnco]|["foot"-tx-16-"foot"-noun-0]|TX|2861/4|
00000000|MMI|2.98|Foot British|C2348704|[qnco]|["foot"-tx-16-"foot"-noun-0]|TX|2861/4|
00000000|MMI|2.98|International Foot|C2346504|[qnco]|["Foot"-tx-16-"foot"-noun-0]|TX|2861/4|
00000000|MMI|2.98|Survey Foot|C2348613|[qnco]|["foot"-tx-16-"foot"-noun-0]|TX|2861/4|
00000000|MMI|2.98|Testing|C0039593|[ftcn]|["Testing"-tx-35-"testing"-noun-0]|TX|4649/7|
00000000|MMI|2.98|Vascular surgeon|C0586909|[prog]|["Vascular surgeon"-tx-42-"vascular surgeon"-noun-0]|TX|4918/16|
00000000|MMI|2.97|Before|C0332152|[tmco]|["Prior"-tx-28-"prior"-adj-0]|TX|4291/5|
00000000|MMI|2.97|HPS4 gene|C1423767|[gngm]|["LE"-tx-16-"LE"-noun-0]|TX|3149/2|
00000000|MMI|2.97|LE, Rat Strain|C2697858|[mamm]|["LE"-tx-16-"LE"-noun-0]|TX|3149/2|
00000000|MMI|2.97|Less Than or Equal to|C0439090|[qnco]|["LE"-tx-16-"LE"-noun-0]|TX|3149/2|
00000000|MMI|2.97|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-41-"DM"-noun-0]|TX|4837/2|
00000000|MMI|2.97|Prior Medication Usage|C2826257|[evnt]|["PRIOR"-tx-28-"prior"-adj-0]|TX|4291/5|
00000000|MMI|2.97|Probable diagnosis|C0332148|[qlco]|["Likely"-tx-41-"likely"-adv-0]|TX|4817/6|
00000000|MMI|2.97|Probably|C0750492|[idcn]|["Likely"-tx-41-"likely"-adv-0]|TX|4817/6|
00000000|MMI|2.97|Recurrent|C2945760|[tmco]|["RECURRENT"-tx-16-"recurrent"-adj-0]|TX|3139/9|
00000000|MMI|2.97|Right sided|C0444532|[spco]|["Right"-tx-17-"right"-noun-0]|TX|3259/5|
00000000|MMI|2.97|compromise|C2945640|[fndg]|["compromise"-tx-21-"compromise"-noun-0]|TX|3575/10|
00000000|MMI|2.97|consider|C0750591|[idcn]|["considering"-tx-17-"considering"-adj-0]|TX|3229/11|
00000000|MMI|2.97|prescribed|C0278329|[hlca]|["Prescribed"-tx-42-"prescribed"-adj-0]|TX|5099/10|
00000000|MMI|2.97|Base|C0178499|[chvf]|["Base"-tx-23-"base"-noun-0]|TX|3764/4|
00000000|MMI|2.97|Dental Base|C1880279|[bodm]|["Base"-tx-23-"base"-noun-0]|TX|3764/4|
00000000|MMI|2.97|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-16-"now"-adv-0]|TX|3085/3|
00000000|MMI|2.97|PACERR gene|C3890506|[gngm]|["PACER"-tx-16-"pacer"-noun-0]|TX|3098/5|
00000000|MMI|2.97|PSMD2 gene|C1419032|[gngm]|["S2"-tx-23-"S2"-noun-0]|TX|3750/2|
00000000|MMI|2.97|RPS2 gene|C1419718|[gngm]|["S2"-tx-23-"S2"-noun-0]|TX|3750/2|
00000000|MMI|2.97|Receive|C1514756|[qlco]|["RECEIVED"-tx-14-"received"-adj-0]|TX|1814/8|
00000000|MMI|2.97|S2|C3812876|[fndg]|["S2"-tx-23-"S2"-noun-1]|TX|3750/2|
00000000|MMI|2.97|S2 innervation|C1179705|[blor]|["S2"-tx-23-"S2"-noun-0]|TX|3750/2|
00000000|MMI|2.97|Structure of base of heart|C0225810|[blor]|["Base"-tx-